SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova informs about outcome of board meeting

19 Jul 2024 Evaluate

Pursuant to the provisions of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Listing Regulations’) (as amended), Jubilant Pharmova has informed that the Board of Directors of the Company has, at its meeting held today on Friday, July 19, 2024 at 12:15 pm that concluded at 02:00 pm, approved the following: Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2024; Grant of 45,448 Stock Options to the eligible employees under the Jubilant Pharmova Employees Stock Option Plan 2018. Pursuant to applicable provisions of the Listing Regulations, it has enclosed the following: The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2024; Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; The details pursuant to SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 Circular dated July 13, 2023 with respect to Stock Options granted to the eligible employees is annexed as Annexure -1. The above-mentioned documents will be simultaneously posted on the Company's website at www.jubilantpharmova.com.

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×